A yeast sterol auxotroph ( erg 25) is rescued by addition of azole antifungals and reduced levels of heme
Open Access
- 14 October 1997
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 94 (21), 11173-11178
- https://doi.org/10.1073/pnas.94.21.11173
Abstract
Genetic disruption of the Saccharomyces cerevisiae C-4 sterol methyl oxidase ERG25 gene leads to sterol auxotrophy. We have characterized a suppression system that requires two mutations to restore viability to this disrupted strain. One suppressor mutation is erg11, which is blocked in 14α-demethylation of lanosterol and is itself an auxotroph. The second suppressor mutation required is either slu1 or slu2 (suppressor of lanosterol utilization). These mutations are leaky versions of HEM2 and HEM4, respectively; addition of exogenous hemin reverses the suppressing effects of slu1 and slu2. Suppression of erg25 by erg11 slu1 (or erg11 slu2) results in a slow-growing strain in which lanosterol, the first sterol in the pathway, accumulates. This result indicates that endogenously synthesized lanosterol can substitute for ergosterol and support growth. In the triple mutants, all but 1 (ERG6) of the 13 subsequent reactions of the ergosterol pathway are inactive. Azole antibiotics (clotrimazole, ketoconazole, and itraconazole) widely used to combat fungal infections are known to do so by inhibiting the ERG11 gene product, the 14α-demethylase. In this investigation, we demonstrate that treatment of the sterol auxotrophs erg25 slu1 or erg25 slu2 with azole antibiotics paradoxically restores viability to these strains in the absence of sterol supplementation via the suppression system we have described.Keywords
This publication has 22 references indexed in Scilit:
- Positive and negative regulation of a sterol biosynthetic gene (ERG3) in the post‐squalene portion of the yeast ergosterol pathwayFEBS Letters, 1996
- Resistance to fluconazole inCandida albicansfrom AIDS patients correlated with reduced intracellular accumulation of drugFEMS Microbiology Letters, 1995
- Adaptation of a Cholesterol Deficient Human T Cell Line to Growth with LanosterolBiochemical and Biophysical Research Communications, 1994
- Cloning, Sequencing, and Disruption of the Gene Encoding Sterol C-14 Reductase in Saccharomyces cerevisiaeDNA and Cell Biology, 1992
- Primary Structure of the P450 Lanosterol Demethylase Gene fromSaccharomyces cerevisiaeDNA, 1987
- Anti-CandidaDrugs — The Biochemical Basis for Their ActivityCRC Critical Reviews in Microbiology, 1987
- Multiple functions for sterols in Saccharomyces cerevisiaeBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Comparative responses of the yeast mutant strain GL7 to lanosterol, cycloartenol, and cyclolaudenolBiochemical and Biophysical Research Communications, 1980
- Yeast mutants blocked in removing the methyl group of lanosterol at C-14. Separation of sterols by high-pressure liquid chromatographyBiochemistry, 1977
- Porphyrin mutants of Saccharomyces cerevisiae: Correlated lesions in sterol and fatty acid biosynthesisBiochemical and Biophysical Research Communications, 1974